A novel cell-based therapy for contusion spinal cord injury using GDNF-delivering NIH3T3 cells with dual reporter genes monitored by molecular imaging

Journal of Nuclear Medicine

Volumn 49, Issue 9, 2008, Pages 1512-1519

  Lo, Wen Cheng ^a   Hsu, Chung Huei ^a   Wu, Alexander T H ^a   Yang, Liang Yo ^b   Chen, Wei Hong ^a   Chiu, Wen Ta ^c   Lai, Wen Fu ^a   Wu, Chih Hsiung ^d   Gelovani, Juri G ^e   Deng, Win Ping ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Animal imaging; GDNF; GFP; Molecular imaging; Neurology; Spinal cord injury

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN 3T3; CELL THERAPY; CONTROLLED STUDY; CONTUSION; EMBRYO CELL; ENGRAFTMENT; FEMALE; FIBROBLAST CULTURE; GENETIC ENGINEERING; GROWTH HORMONE RELEASE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SPINAL CORD INJURY;

ANIMALS; CONTUSIONS; FEMALE; GENES, REPORTER; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MICE; MOLECULAR PROBE TECHNIQUES; NIH 3T3 CELLS; RATS; RATS, LONG-EVANS; SPINAL CORD INJURIES; THORACIC VERTEBRAE; TREATMENT OUTCOME;

EID: 51349141776     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.051896     Document Type: Article

References (31)

1. Fehlings MG, Sekhon LH, Tator C. The role and timing of decompression in acute spinal cord injury: what do we know? What should we do? Spine. 2001;26(suppl 24):S101-S110.
2. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med. 1997;3:73-76.
3. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 1993;260:1130-1132.
4. Arenas E, Trupp M, Akerud P, Ibanez CF. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron. 1995;15:1465-1473.
5. Wang Y, Lin SZ, Chiou AL, Williams LR, Hoffer BJ. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J Neurosci. 1997;17:4341-4348.
6. Klocker N, Braunling F, Isenmann S, Bahr M. In vivo neurotrophic effects of GDNF on axotomized retinal ganglion cells. Neuroreport. 1997;8:3439-3442.
7. Molliver DC, Wright DE, Leitner ML, et al. IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron. 1997;19:849-861.
8. Bennett DL, Michael GJ, Ramachandran N, et al. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci. 1998;18:3059-3072.
9. Henderson CE, Phillips HS, Pollock RA, et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science. 1994;266:1062-1064.
10. Blesch A, Tuszynski MH. GDNF gene delivery to injured adult CNS motor neurons promotes axonal growth, expression of the trophic neuropeptide CGRP, and cellular protection. J Comp Neurol. 2001;436:399-410.
11. Zhou L, Shine HD. Neurotrophic factors expressed in both cortex and spinal cord induce axonal plasticity after spinal cord injury. J Neurosci Res. 2003;74:221-226.
12. Moraleda JM, Blanquer M, Bleda P, et al. Adult stem cell therapy: dream or reality? Transpl Immunol. 2006;17:74-77.
13. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci USA. 2005;102:14069-14074.
14. Iwanami A, Kaneko S, Nakamura M, et al. Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res. 2005;80:182-190.
15. Watanabe K, Nakamura M, Iwanami A, et al. Comparison between fetal spinal-cord-and forebrain-derived neural stem/progenitor cells as a source of transplantation for spinal cord injury. Dev Neurosci. 2004;26:275-287.
16. Reier PJ. Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx. 2004;1:424-451.
17. Ourednik J, Ourednik V. Graft-induced plasticity in the mammalian host CNS. Cell Transplant. 2004;13:307-318.
18. Ourednik V, Ourednik J. Multifaceted dialogue between graft and host in neurotransplantation. J Neurosci Res. 2004;76:193-204.
19. Hung SC, Deng WP, Yang WK, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res. 2005;11:7749-7756.
20. Ma D, Wang X, Han J. NIH 3T3 cells or engineered NIH 3T3 cells stably expressing GDNF can protect primary dopaminergic neurons. Neurol Res. 2000;22:538-544.
21. Rubin H. 'Spontaneous' transformation as aberrant epigenesis. Differentiation. 1993;53:123-137.
22. Tsai MS, Hwang SM, Tsai YL, Cheng FC, Lee JL, Chang YJ. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod. 2006;74:545-551.
23. Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol. 1996;139:244-256.
24. Deng WP, Wu CC, Lee CC, et al. Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir. J Nucl Med. 2006;47:877-884.
25. Ray P, Bauer E, Iyer M, et al. Monitoring gene therapy with reporter gene imaging. Semin Nucl Med. 2001;31:312-320.
26. Lu P, Tuszynski MH. Growth factors and combinatorial therapies for CNS regeneration. Exp Neurol. 2008;209:313-320.
27. Hammarberg H, Piehl F, Cullheim S, Fjell J, Hokfelt T, Fried K. GDNF mRNA in Schwann cells and DRG satellite cells after chronic sciatic nerve injury. Neuroreport. 1996;7:857-860.
28. Houenou LJ, Oppenheim RW, Li L, Lo AC, Prevette D. Regulation of spinal motoneuron survival by GDNF during development and following injury. Cell Tissue Res. 1996;286:219-223.
29. Li L, Wu W, Lin LF, Lei M, Oppenheim RW, Houenou LJ. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc Natl Acad Sci USA. 1995;92:9771-9775.
30. 3 and dexamethasone in vitro. J Cell Physiol. 2002;193:164-172.
31. Satake K, Matsuyama Y, Kamiya M, et al. Up-regulation of glial cell line-derived neurotrophic factor (GDNF) following traumatic spinal cord injury. Neuroreport. 2000;11:3877-3881.